Zhen Su: Another Sea Change of oncology care led by cancer immunotherapy

Zhen Su, Physician Scientist, Entrepreneur and CEO at Marengo Therapeutics, shared a post on LinkedIn:

“Another Sea Change of oncology care led by cancer immunotherapy: 5 new IO therapeutics have been approved for the over the past 2 years and brought significant clinical benefits for patients. The rapid evolution of the MM treatment landscape is highlighted in this nice review by Ajay K. Nooka, MD, MPH.”

Source: Zhen Su/LinkedIn